A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Clinical trial NCT02161757 · COMPLETED
Trial details
- NCT number
- NCT02161757
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-13
- Primary completion
- 2017-02-28
- Enrollment
- 1207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.